<DOC>
	<DOCNO>NCT01147159</DOCNO>
	<brief_summary>Allergen extract complex mixture proteins contain vary amount allergenic non-allergenic component . Many factor biovariability , difference extraction process subsequent handling allergen affect final composition , potency , stability allergen preparation . Genetic diversity affect people add another level complexity . In order control variability achieve consistency reproducibility optimal safety sensitivity/specificity , essential standardize amount allergen use prick test . Therefore , system biological standardization mainly use Europe still biological calibration in-House Reference Preparations ( IHRP ) . The method adopt Nordic Council Medicines Nordic Biological Unit , Histamine Equivalent Potency ( HEP ) Skin Prick Test ( SPT ) value . The aim procedure estimate biological activity allergen extract . The activity allergen extract define 10,000 Diagnostic Biological Units ( DBU ) per ml ( 1 SPT per ml ) , extract provokes specific skin reaction wheal size wheal provoke reference histamine concentration 10 mg/ml , solution administrate use technique ( prick test ) least 20 individual clinically allergic cutaneously reactive allergen concern . The present study aim standardize allergen extract Betula pendula , Phleum pratense Dermatophagoides pteronyssinus use method . - Trial medicinal product</brief_summary>
	<brief_title>Biological Standardization Allergen Extracts Pollens Betula Pendula , Phleum Pratense Mite Extract Dermatophagoides Pteronyssinus</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Positive clinical history inhalant allergy least one allergen standardize . At least one positive prick test ( mean wheal diameter = 3mm ) test already standardize extract allergens investigation . Positive prick test ( wheal diameter =3 mm ) Histamine 10 mg/ml Age : 1860 year Written inform consent Exclusion criterion : Diseases medication , influence skin test contradict correct conduct evaluation study . Pregnancy , skin irritation , drug alcohol abuse participation another clinical trial within last 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>